[
  {
    "objectID": "UPDATE_NOTES.html",
    "href": "UPDATE_NOTES.html",
    "title": "",
    "section": "",
    "text": "Code"
  },
  {
    "objectID": "UPDATE_NOTES.html#update-december-27-2025",
    "href": "UPDATE_NOTES.html#update-december-27-2025",
    "title": "",
    "section": "Update: December 27, 2025",
    "text": "Update: December 27, 2025\n\nNew Section Added: Genotype-Phenotype Relationships\nA comprehensive analysis of the relationship between beta-lactamase genes and antimicrobial susceptibility has been added to the report."
  },
  {
    "objectID": "UPDATE_NOTES.html#what-was-added",
    "href": "UPDATE_NOTES.html#what-was-added",
    "title": "",
    "section": "What Was Added",
    "text": "What Was Added\n\nSection: â€œGenotype-Phenotype Relationshipsâ€\nLocation: Between â€œResistance Genotypesâ€ and â€œCapsular Type-Resistance Associationsâ€\nSize: 376 lines of new content"
  },
  {
    "objectID": "UPDATE_NOTES.html#content-overview",
    "href": "UPDATE_NOTES.html#content-overview",
    "title": "",
    "section": "Content Overview",
    "text": "Content Overview\n\n1. Beta-lactamase Gene Burden Analysis\n\nDistribution of additional genes (excluding universal KPC-31)\n50% of isolates have no additional beta-lactamases\nUp to 4 additional genes per isolate\n\n\n\n2. MIC by Gene Burden\n\nKey Finding: No dose-response relationship\nParadox: 4 genes = lowest median MIC (12 mg/L)\n0 genes = wide MIC range (4-644 mg/L, 161-fold!)\n\n\n\n3. Individual Gene Effects\n\nMedian MIC for isolates carrying each gene\nblaSHV-11 carriers: highest median (256 mg/L)\nContext-dependent effects observed\n\n\n\n4. Clone-Specific Patterns\n\nST307 Paradox: Most genes (CTX-M-15 + SHV-28) but LOWEST MIC\nST101: Few genes but HIGHEST MIC (256 mg/L)\nST512: IncX3 plasmid-borne KPC-31\nST147: Multiple genes, high MIC as expected\n\n\n\n5. Gene Combination Effects\n\nCTX-M-15 + SHV-28: Highest synergy (256 mg/L)\nCTX-M-15 + TEM: Lower MIC (12 mg/L)\nContext-dependent, non-additive effects\n\n\n\n6. Mechanistic Insights (Tabbed Panels)\n\nKPC-31 Dominance: Universal but variable expression\nSynergistic Effects: Epistatic interactions\nClone Effects: Genetic background critical\nClinical Implications: Both WGS + MIC needed"
  },
  {
    "objectID": "UPDATE_NOTES.html#visualizations-added",
    "href": "UPDATE_NOTES.html#visualizations-added",
    "title": "",
    "section": "Visualizations Added",
    "text": "Visualizations Added\n\nBoxplot: MIC by number of beta-lactamase genes\nBar Chart: Median MIC for each individual gene\nScatter Plot: Clone-specific genotype-phenotype relationships\nMultiple Tables:\n\nGene burden distribution\nMIC statistics by gene count\nClone-specific profiles\nGene combination effects\nSummary findings"
  },
  {
    "objectID": "UPDATE_NOTES.html#key-discoveries-highlighted",
    "href": "UPDATE_NOTES.html#key-discoveries-highlighted",
    "title": "",
    "section": "Key Discoveries Highlighted",
    "text": "Key Discoveries Highlighted\n\nğŸ”¬ Major Finding\nComplex, non-linear genotype-phenotype relationships: - Same genes â†’ different phenotypes in different clones - More genes â‰  higher resistance - Clone identity is critical\n\n\nâš ï¸ The ST307 Paradox\n\nMost additional genes: CTX-M-15 (10/16), SHV-28 (13/16)\nLowest median MIC: 18 mg/L\nHypothesis: Chromosomal KPC-31 with lower expression\n\n\n\nâœ“ Clinical Relevance\n\nGenotype alone insufficient for treatment decisions\nPhenotypic testing (MIC) essential\nIntegration needed: WGS + MIC + MLST"
  },
  {
    "objectID": "UPDATE_NOTES.html#how-to-use-the-updated-report",
    "href": "UPDATE_NOTES.html#how-to-use-the-updated-report",
    "title": "",
    "section": "How to Use the Updated Report",
    "text": "How to Use the Updated Report\n\nRender the Report\nquarto render resistome_analysis_report.qmd\n\n\nPreview Locally\nquarto preview resistome_analysis_report.qmd\n\n\nPush to GitHub (for website update)\ngit add resistome_analysis_report.qmd\ngit commit -m \"Add genotype-phenotype analysis section\"\ngit push\nWebsite will update automatically in 1-2 minutes!"
  },
  {
    "objectID": "UPDATE_NOTES.html#section-structure",
    "href": "UPDATE_NOTES.html#section-structure",
    "title": "",
    "section": "Section Structure",
    "text": "Section Structure\nThe new section includes:\n# Genotype-Phenotype Relationships\nâ”œâ”€â”€ Introduction & Key Finding callout\nâ”œâ”€â”€ Beta-lactamase Gene Burden\nâ”‚   â”œâ”€â”€ Distribution table\nâ”‚   â””â”€â”€ Note about 50% having no additional genes\nâ”œâ”€â”€ MIC by Gene Burden\nâ”‚   â”œâ”€â”€ Boxplot visualization\nâ”‚   â”œâ”€â”€ Summary statistics table\nâ”‚   â””â”€â”€ Paradox warning callout\nâ”œâ”€â”€ Individual Gene Effects\nâ”‚   â””â”€â”€ Bar chart of median MICs\nâ”œâ”€â”€ Clone-Specific Patterns\nâ”‚   â”œâ”€â”€ Scatter plot with gene profiles\nâ”‚   â”œâ”€â”€ Clone profile table\nâ”‚   â””â”€â”€ ST307 paradox callout\nâ”œâ”€â”€ Gene Combination Effects\nâ”‚   â””â”€â”€ Combination analysis table\nâ”œâ”€â”€ Key Mechanistic Insights\nâ”‚   â”œâ”€â”€ KPC-31 Dominance (tab)\nâ”‚   â”œâ”€â”€ Synergistic Effects (tab)\nâ”‚   â”œâ”€â”€ Clone Effects (tab)\nâ”‚   â””â”€â”€ Clinical Implications (tab)\nâ”œâ”€â”€ Summary Table\nâ””â”€â”€ Research Implications (tip callout)"
  },
  {
    "objectID": "UPDATE_NOTES.html#technical-details",
    "href": "UPDATE_NOTES.html#technical-details",
    "title": "",
    "section": "Technical Details",
    "text": "Technical Details\n\nCode Blocks Added\n\n6 major visualizations\n7 summary tables\n4 callout boxes (important, warning, note, tip)\n1 tabbed panel with 4 tabs\n\n\n\nData Analysis\n\nAnalysis of 42 isolates\n7 beta-lactamase genes examined\n5 sequence types compared\nMultiple statistical summaries"
  },
  {
    "objectID": "UPDATE_NOTES.html#what-this-adds-to-your-analysis",
    "href": "UPDATE_NOTES.html#what-this-adds-to-your-analysis",
    "title": "",
    "section": "What This Adds to Your Analysis",
    "text": "What This Adds to Your Analysis\n\nBefore\n\nGene presence/absence data\nIndividual gene prevalence\nBasic gene profiles by clone\n\n\n\nAfter\n\nGenotype-phenotype correlation analysis\nClone-specific patterns\nGene combination effects\nMechanistic insights\nClinical decision support\nResearch hypotheses"
  },
  {
    "objectID": "UPDATE_NOTES.html#next-steps",
    "href": "UPDATE_NOTES.html#next-steps",
    "title": "",
    "section": "Next Steps",
    "text": "Next Steps\n\nâœ… Section added to report\nâ¬œ Render locally to verify: quarto render\nâ¬œ Review the new section in HTML output\nâ¬œ Push to GitHub for website update\nâ¬œ Share with collaborators"
  },
  {
    "objectID": "UPDATE_NOTES.html#notes",
    "href": "UPDATE_NOTES.html#notes",
    "title": "",
    "section": "Notes",
    "text": "Notes\n\nAll code is embedded and reproducible\nTables are interactive (sortable/searchable)\nFigures are high-resolution\nSection flows naturally with existing content\nMaintains consistent styling and formatting\n\n\nQuestions? The new section is fully integrated and ready to use!"
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About This Project",
    "section": "",
    "text": "This website presents a comprehensive analysis of 42 bacterial isolates from the KPC-31 resistome project, focusing on carbapenemase-producing Klebsiella pneumoniae and Escherichia coli."
  },
  {
    "objectID": "about.html#project-overview",
    "href": "about.html#project-overview",
    "title": "About This Project",
    "section": "",
    "text": "This website presents a comprehensive analysis of 42 bacterial isolates from the KPC-31 resistome project, focusing on carbapenemase-producing Klebsiella pneumoniae and Escherichia coli."
  },
  {
    "objectID": "about.html#data-source",
    "href": "about.html#data-source",
    "title": "About This Project",
    "section": "Data Source",
    "text": "Data Source\nDataset: Progetto 1 (KPC-31) versione 2.xlsx\nThe dataset includes: - 42 bacterial isolates - 155 variables covering: - Bacterial identification (species, MLST, capsular typing) - Antimicrobial susceptibility testing (MIC for ~26 antibiotics) - Resistance gene detection (36 genes) - Plasmid replicon typing (15 incompatibility groups)"
  },
  {
    "objectID": "about.html#methodology",
    "href": "about.html#methodology",
    "title": "About This Project",
    "section": "Methodology",
    "text": "Methodology\n\nBacterial Characterization\n\nSpecies identification: Standard microbiological methods\nMulti-locus sequence typing (MLST): Sequence type determination\nCapsular typing (KL): K-locus characterization\nWzi typing: Capsule synthesis region analysis\n\n\n\nAntimicrobial Susceptibility Testing\nMIC (Minimum Inhibitory Concentration) values determined for approximately 26 antibiotics including: - Beta-lactams (including carbapenems) - Beta-lactam/beta-lactamase inhibitor combinations (CAZ-AVI, PIP-TAZ) - Aminoglycosides - Quinolones - Colistin\nResistance Interpretation: - CAZ-AVI Susceptible: MIC â‰¤8 mg/L - CAZ-AVI Intermediate: MIC 9-16 mg/L - CAZ-AVI Resistant: MIC &gt;16 mg/L\n\n\nMolecular Analysis\n\nResistance Gene Detection\n36 resistance genes analyzed including: - Beta-lactamases: blaKPC-31, blaCTX-M-15, blaTEM, blaSHV variants, blaOXA - Aminoglycoside resistance: aac, aph, ant genes, armA (16S rRNA methylase) - Quinolone resistance: qnrB1, gyrA/ParC mutations - Other mechanisms: Sul1/Sul2 (sulfonamides), fosA (fosfomycin)\n\n\nPlasmid Typing\n15 incompatibility groups detected: - IncFIB(K), IncFII(K) - K. pneumoniae-specific IncF plasmids - IncX3 - Small mobilizable plasmid - IncR - Broad host range - IncN - Broad host range - Multiple other Inc groups\n\n\n\nData Analysis\nAll analyses performed using: - R version: 4.5.1 - Platform: Positron 2025.12.2 - Key packages: - tidyverse (v2.0.0) - data manipulation and visualization - readxl (v1.4.3) - Excel file import - ggplot2 (v4.0.1) - graphics - knitr and kableExtra - table formatting\n\n\nStatistical Methods\n\nDescriptive statistics (counts, percentages, medians)\nLog2 transformation for MIC visualization\nHierarchical clustering for resistance patterns\nChi-square and Fisherâ€™s exact tests where appropriate"
  },
  {
    "objectID": "about.html#limitations",
    "href": "about.html#limitations",
    "title": "About This Project",
    "section": "Limitations",
    "text": "Limitations\n\nSample size: Limited to 42 isolates\nCapsular typing: Only 23.8% (10/42) isolates have KL typing\nMissing data: Variable completeness across different data types\nPlasmid detection: 62% of isolates have no detectable Inc groups (possible chromosomal integration or novel plasmids)\nCross-sectional design: No temporal or longitudinal data available"
  },
  {
    "objectID": "about.html#key-definitions",
    "href": "about.html#key-definitions",
    "title": "About This Project",
    "section": "Key Definitions",
    "text": "Key Definitions\n\nMolecular Typing\n\nST (Sequence Type): Classification based on multi-locus sequence typing (MLST) of housekeeping genes\nKL (Capsular Type): Classification based on K-locus genetic structure\nHigh-risk clone: Globally disseminated sequence types associated with multidrug resistance and virulence\n\n\n\nResistance Mechanisms\n\nCarbapenemase: Enzyme that hydrolyzes carbapenem antibiotics (e.g., KPC-31)\nESBL: Extended-spectrum beta-lactamase (e.g., CTX-M-15)\n16S rRNA methylase: Enzyme conferring pan-aminoglycoside resistance (e.g., armA)\n\n\n\nPlasmid Biology\n\nInc group: Incompatibility group - plasmids classification based on replication systems\nHGT: Horizontal gene transfer - movement of genetic material between bacteria\nConjugation: Transfer of plasmids between bacteria via cell-to-cell contact"
  },
  {
    "objectID": "about.html#data-availability",
    "href": "about.html#data-availability",
    "title": "About This Project",
    "section": "Data Availability",
    "text": "Data Availability\nThe analysis code and this website are available on GitHub. The raw dataset is not publicly available due to potential patient privacy concerns."
  },
  {
    "objectID": "about.html#reproducibility",
    "href": "about.html#reproducibility",
    "title": "About This Project",
    "section": "Reproducibility",
    "text": "Reproducibility\nThis analysis is fully reproducible. All code used to generate the figures and tables is embedded in the Quarto documents and can be viewed using the â€œCodeâ€ buttons throughout the report."
  },
  {
    "objectID": "about.html#ai-assistance-disclosure",
    "href": "about.html#ai-assistance-disclosure",
    "title": "About This Project",
    "section": "AI Assistance Disclosure",
    "text": "AI Assistance Disclosure\n\n\n\n\n\n\nNote\n\n\n\nThis analysis was conducted with AI assistance (Databot in Positron) under human direction. All findings should be verified by qualified microbiologists and epidemiologists before clinical or public health decisions."
  },
  {
    "objectID": "about.html#contact",
    "href": "about.html#contact",
    "title": "About This Project",
    "section": "Contact",
    "text": "Contact\nFor questions about this analysis, please contact:\n[Your contact information here]"
  },
  {
    "objectID": "about.html#acknowledgments",
    "href": "about.html#acknowledgments",
    "title": "About This Project",
    "section": "Acknowledgments",
    "text": "Acknowledgments\n\nData collection and laboratory analysis: [Your team/institution]\nBioinformatics analysis: [Your name/team]\nComputational resources: [Institution/facility]"
  },
  {
    "objectID": "about.html#citation",
    "href": "about.html#citation",
    "title": "About This Project",
    "section": "Citation",
    "text": "Citation\nIf you use this analysis or data, please cite:\n[Your preferred citation format]"
  },
  {
    "objectID": "about.html#technical-notes",
    "href": "about.html#technical-notes",
    "title": "About This Project",
    "section": "Technical Notes",
    "text": "Technical Notes\n\nWebsite Generation\nThis website was created using: - Quarto (v1.4+) - Scientific and technical publishing system - GitHub Pages - Free static website hosting - R Markdown - Dynamic document generation\n\n\nRendering\nTo regenerate this website locally:\n# Install Quarto (https://quarto.org/docs/get-started/)\n\n# Clone the repository\ngit clone https://github.com/Russlewisbo/resistome.git\ncd resistome\n\n# Render the website\nquarto render\n\n# Preview locally\nquarto preview\n\n\nSoftware Versions\n\nR: 4.5.1\nQuarto: 1.4+\nRStudio/Positron: 2025.12.2\n\n\nLast updated: December 27, 2025"
  },
  {
    "objectID": "WORKFLOW.html",
    "href": "WORKFLOW.html",
    "title": "",
    "section": "",
    "text": "Code"
  },
  {
    "objectID": "WORKFLOW.html#your-files-github-website",
    "href": "WORKFLOW.html#your-files-github-website",
    "title": "",
    "section": "Your Files â†’ GitHub â†’ Website",
    "text": "Your Files â†’ GitHub â†’ Website\nâ”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”\nâ”‚                    YOUR LOCAL COMPUTER                       â”‚\nâ”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤\nâ”‚                                                               â”‚\nâ”‚  ğŸ“ Your Project Folder                                      â”‚\nâ”‚  â”œâ”€â”€ index.qmd                    â† Homepage                 â”‚\nâ”‚  â”œâ”€â”€ resistome_analysis_report.qmd â† Full Report            â”‚\nâ”‚  â”œâ”€â”€ about.qmd                    â† About Page               â”‚\nâ”‚  â”œâ”€â”€ _quarto.yml                  â† Configuration            â”‚\nâ”‚  â”œâ”€â”€ styles.css                   â† Styling                  â”‚\nâ”‚  â””â”€â”€ Progetto 1 (KPC-31)...xlsx  â† Data                     â”‚\nâ”‚                                                               â”‚\nâ”‚  ğŸ’» Step 1: Edit files in Positron/RStudio                   â”‚\nâ”‚                                                               â”‚\nâ”‚  âš¡ Step 2: Run: quarto render                               â”‚\nâ”‚       â”‚                                                       â”‚\nâ”‚       â”œâ”€â†’ Creates docs/ folder with HTML files               â”‚\nâ”‚       â”‚                                                       â”‚\nâ”‚       â””â”€â†’ docs/                                              â”‚\nâ”‚           â”œâ”€â”€ index.html                                     â”‚\nâ”‚           â”œâ”€â”€ resistome_analysis_report.html                 â”‚\nâ”‚           â”œâ”€â”€ about.html                                     â”‚\nâ”‚           â””â”€â”€ (all plots, tables, etc.)                      â”‚\nâ”‚                                                               â”‚\nâ””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜\n                         â”‚\n                         â”‚ git push\n                         â†“\nâ”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”\nâ”‚                         GITHUB                               â”‚\nâ”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤\nâ”‚                                                               â”‚\nâ”‚  ğŸ™ Your Repository: username/kpc31-resistome-analysis      â”‚\nâ”‚                                                               â”‚\nâ”‚  main branch:                                                â”‚\nâ”‚  â”œâ”€â”€ All your .qmd files                                    â”‚\nâ”‚  â”œâ”€â”€ _quarto.yml                                            â”‚\nâ”‚  â””â”€â”€ docs/ â† GitHub Pages serves from here!                 â”‚\nâ”‚      â”œâ”€â”€ index.html                                         â”‚\nâ”‚      â”œâ”€â”€ resistome_analysis_report.html                     â”‚\nâ”‚      â””â”€â”€ ...                                                â”‚\nâ”‚                                                               â”‚\nâ””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜\n                         â”‚\n                         â”‚ GitHub Pages\n                         â”‚ (automatic)\n                         â†“\nâ”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”\nâ”‚                    LIVE WEBSITE ğŸŒ                          â”‚\nâ”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤\nâ”‚                                                               â”‚\nâ”‚  ğŸŒ https://username.github.io/kpc31-resistome-analysis/    â”‚\nâ”‚                                                               â”‚\nâ”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚\nâ”‚  â”‚  ğŸ  Homepage                             â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Quick Summary                        â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Key Findings                         â”‚               â”‚\nâ”‚  â”‚  â””â”€ Links to Full Report                 â”‚               â”‚\nâ”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚\nâ”‚                                                               â”‚\nâ”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚\nâ”‚  â”‚  ğŸ“Š Full Report                          â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ All analyses                         â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Interactive plots                    â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Tables                               â”‚               â”‚\nâ”‚  â”‚  â””â”€ Collapsible code                     â”‚               â”‚\nâ”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚\nâ”‚                                                               â”‚\nâ”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚\nâ”‚  â”‚  â„¹ï¸  About Page                          â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Methods                              â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Data sources                         â”‚               â”‚\nâ”‚  â”‚  â””â”€ Technical details                    â”‚               â”‚\nâ”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚\nâ”‚                                                               â”‚\nâ”‚  Anyone can access this URL! ğŸ‰                             â”‚\nâ”‚                                                               â”‚\nâ””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜"
  },
  {
    "objectID": "WORKFLOW.html#update-workflow",
    "href": "WORKFLOW.html#update-workflow",
    "title": "",
    "section": "ğŸ”„ Update Workflow",
    "text": "ğŸ”„ Update Workflow\nEdit .qmd â†’ quarto render â†’ git push â†’ Website updates!\n   ğŸ“            âš¡             ğŸš€           âœ¨\n (2 min)      (1 min)       (1 min)    (1-2 min)"
  },
  {
    "objectID": "WORKFLOW.html#checklist",
    "href": "WORKFLOW.html#checklist",
    "title": "",
    "section": "ğŸ“‹ Checklist",
    "text": "ğŸ“‹ Checklist\n\nOne-Time Setup\n\nCreate GitHub repository\nEdit _quarto.yml (update username/repo)\nRun quarto render\nPush to GitHub\nEnable GitHub Pages in Settings\nWait 2 minutes\nVisit your website!\n\n\n\nEvery Update\n\nEdit files\nRun quarto render\ngit add . && git commit && git push\nWait 1-2 minutes\nRefresh website"
  },
  {
    "objectID": "WORKFLOW.html#key-points",
    "href": "WORKFLOW.html#key-points",
    "title": "",
    "section": "ğŸ¯ Key Points",
    "text": "ğŸ¯ Key Points\n\nEdit locally - Work on .qmd files in Positron\nRender locally - quarto render creates HTML\nPush to GitHub - Git uploads everything\nGitHub Pages - Automatically serves from docs/ folder\nWebsite updates - Takes 1-2 minutes to go live"
  },
  {
    "objectID": "WORKFLOW.html#data-privacy-options",
    "href": "WORKFLOW.html#data-privacy-options",
    "title": "",
    "section": "ğŸ”’ Data Privacy Options",
    "text": "ğŸ”’ Data Privacy Options\n\nOption 1: Keep Data Public\nâ””â”€â”€ Data included in GitHub (anyone can download)\n\n\nOption 2: Keep Data Private\n1. Uncomment *.xlsx in .gitignore\n2. git rm --cached \"*.xlsx\"\n3. Users need local copy to run code\n4. Website still shows all results (already rendered)"
  },
  {
    "objectID": "WORKFLOW.html#what-makes-this-special",
    "href": "WORKFLOW.html#what-makes-this-special",
    "title": "",
    "section": "ğŸŒŸ What Makes This Special",
    "text": "ğŸŒŸ What Makes This Special\n\nâœ… Free - GitHub Pages is free for public repos\nâœ… Fast - Updates in minutes\nâœ… Professional - Clean, modern design\nâœ… Interactive - All plots and tables work\nâœ… Mobile-friendly - Works on phones/tablets\nâœ… Shareable - Just share the URL\nâœ… Version controlled - Full history with git"
  },
  {
    "objectID": "WORKFLOW.html#tips",
    "href": "WORKFLOW.html#tips",
    "title": "",
    "section": "ğŸ’¡ Tips",
    "text": "ğŸ’¡ Tips\n\nUse quarto preview to see changes before pushing\nHard refresh (Ctrl+Shift+R) if changes donâ€™t show\nCheck GitHub Actions tab to see deployment status\nCustom domain possible (see GitHub Pages docs)\n\n\nNext: Open QUICKSTART.md for step-by-step commands!"
  },
  {
    "objectID": "QUICKSTART.html",
    "href": "QUICKSTART.html",
    "title": "",
    "section": "",
    "text": "Code"
  },
  {
    "objectID": "QUICKSTART.html#minute-setup",
    "href": "QUICKSTART.html#minute-setup",
    "title": "",
    "section": "5-Minute Setup",
    "text": "5-Minute Setup\n\n1ï¸âƒ£ Create GitHub Repository (2 min)\n1. Go to: https://github.com/new\n2. Name: kpc31-resistome-analysis\n3. Public âœ…\n4. Add README âœ…\n5. Click \"Create repository\"\n\n\n2ï¸âƒ£ Prepare Files (1 min)\n# In your terminal (where your files are):\ncd /path/to/your/project\n\n# Edit _quarto.yml line 13:\n# Change: YOUR-USERNAME to your GitHub username\n# Change: YOUR-REPO-NAME to kpc31-resistome-analysis\n\n# Render website\nquarto render\n\n\n3ï¸âƒ£ Push to GitHub (1 min)\ngit init\ngit add .\ngit commit -m \"Initial commit\"\ngit remote add origin https://github.com/YOUR-USERNAME/kpc31-resistome-analysis.git\ngit branch -M main\ngit push -u origin main\n\n\n4ï¸âƒ£ Enable GitHub Pages (1 min)\n1. Go to: https://github.com/YOUR-USERNAME/kpc31-resistome-analysis\n2. Click: Settings â†’ Pages\n3. Source: Deploy from a branch\n4. Branch: main\n5. Folder: /docs\n6. Save\n\n\nâœ… Done!\nYour site will be live in 1-2 minutes at:\nhttps://YOUR-USERNAME.github.io/kpc31-resistome-analysis/"
  },
  {
    "objectID": "QUICKSTART.html#to-update-website-later",
    "href": "QUICKSTART.html#to-update-website-later",
    "title": "",
    "section": "ğŸ”„ To Update Website Later",
    "text": "ğŸ”„ To Update Website Later\n# 1. Make your changes to .qmd files\n# 2. Re-render\nquarto render\n\n# 3. Push changes\ngit add .\ngit commit -m \"Update analysis\"\ngit push\nWebsite updates automatically in 1-2 minutes!"
  },
  {
    "objectID": "QUICKSTART.html#common-issues",
    "href": "QUICKSTART.html#common-issues",
    "title": "",
    "section": "â“ Common Issues",
    "text": "â“ Common Issues\nQ: Website shows 404? - A: Wait 2-3 minutes after first setup - Check Settings â†’ Pages shows â€œpublishedâ€\nQ: Changes not showing? - A: Did you run quarto render before pushing? - Try hard refresh: Ctrl+Shift+R (Windows) or Cmd+Shift+R (Mac)\nQ: How do I keep data private? - A: In .gitignore, uncomment: # *.xlsx - Then: git rm --cached \"*.xlsx\" and push"
  },
  {
    "objectID": "QUICKSTART.html#share-your-website",
    "href": "QUICKSTART.html#share-your-website",
    "title": "",
    "section": "ğŸ“± Share Your Website",
    "text": "ğŸ“± Share Your Website\nOnce live, share this link:\nhttps://YOUR-USERNAME.github.io/kpc31-resistome-analysis/\nThe website works on: - ğŸ’» Desktop browsers - ğŸ“± Mobile devices - ğŸ“Š Contains all interactive plots and tables - ğŸ” Searchable and navigable\n\nNeed detailed help? See README.md\nProblems? Check: https://quarto.org/docs/troubleshooting/"
  },
  {
    "objectID": "resistome_analysis_report.html",
    "href": "resistome_analysis_report.html",
    "title": "Comprehensive Resistome Analysis",
    "section": "",
    "text": "This report presents a comprehensive analysis of 42 bacterial isolates from the KPC-31 resistome project. The dataset includes detailed characterization of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates, with emphasis on:\n\nSpecies and molecular typing (sequence types, capsular types)\nAntimicrobial resistance phenotypes (MIC values for 26 antibiotics)\nResistance genotypes (36 resistance genes identified)\nPlasmid incompatibility groups (15 Inc groups detected)\nHorizontal gene transfer patterns\n\n\n\n\n\n\n\n\n\nImportantCritical Discovery: Universal blaKPC-31 Carriage\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, indicating this is a KPC-31-specific collection or outbreak. This variant is responsible for the observed carbapenem resistance and variable ceftazidime-avibactam (CAZ-AVI) resistance across isolates.\n\n\n\nDominant species: Klebsiella pneumoniae (78.6%, n=33)\nMost prevalent sequence type: ST307 (50% of typed isolates, n=16)\nHigh-risk clones identified: ST307, ST512, ST101, ST131, ST147\nCAZ-AVI resistance: 35.7% show high-level resistance (MIC &gt;16 mg/L)\nPlasmid diversity: 15 incompatibility groups, with IncF plasmids spreading across multiple clones"
  },
  {
    "objectID": "resistome_analysis_report.html#key-findings",
    "href": "resistome_analysis_report.html#key-findings",
    "title": "Comprehensive Resistome Analysis",
    "section": "",
    "text": "ImportantCritical Discovery: Universal blaKPC-31 Carriage\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, indicating this is a KPC-31-specific collection or outbreak. This variant is responsible for the observed carbapenem resistance and variable ceftazidime-avibactam (CAZ-AVI) resistance across isolates.\n\n\n\nDominant species: Klebsiella pneumoniae (78.6%, n=33)\nMost prevalent sequence type: ST307 (50% of typed isolates, n=16)\nHigh-risk clones identified: ST307, ST512, ST101, ST131, ST147\nCAZ-AVI resistance: 35.7% show high-level resistance (MIC &gt;16 mg/L)\nPlasmid diversity: 15 incompatibility groups, with IncF plasmids spreading across multiple clones"
  },
  {
    "objectID": "resistome_analysis_report.html#data-structure",
    "href": "resistome_analysis_report.html#data-structure",
    "title": "Comprehensive Resistome Analysis",
    "section": "1.1 Data Structure",
    "text": "1.1 Data Structure\n\n\nDataset Dimensions:\n\n\n==================\n\n\nâ€¢ Total isolates: 42\n\n\nâ€¢ Total variables: 155\n\n\nâ€¢ Antibiotics tested (MIC): ~26\n\n\nâ€¢ Resistance genes analyzed: 36\n\n\nâ€¢ Plasmid Inc groups detected: 15"
  },
  {
    "objectID": "resistome_analysis_report.html#data-completeness",
    "href": "resistome_analysis_report.html#data-completeness",
    "title": "Comprehensive Resistome Analysis",
    "section": "1.2 Data Completeness",
    "text": "1.2 Data Completeness\n\n\n\n\nTableÂ 1: Data completeness for key metadata variables\n\n\n\n\n\n\nVariable\nTotal\nComplete\nMissing\n% Complete\n\n\n\n\nID\n42\n42\n0\n100.0\n\n\nSpecies\n42\n42\n0\n100.0\n\n\nClinical Source\n42\n32\n10\n76.2\n\n\nSequence Type (ST)\n42\n32\n10\n76.2\n\n\nCapsular Type (KL)\n42\n10\n32\n23.8\n\n\nWzi Type\n42\n9\n33\n21.4"
  },
  {
    "objectID": "resistome_analysis_report.html#species-distribution",
    "href": "resistome_analysis_report.html#species-distribution",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.1 Species Distribution",
    "text": "2.1 Species Distribution\n\n\n\n\n\n\n\n\nFigureÂ 1: Distribution of bacterial species in the collection\n\n\n\n\n\n\n\n\n\n\n\nNoteSpecies Composition\n\n\n\n\nKlebsiella pneumoniae: 33/42 isolates (78.6%)\nEscherichia coli variants: 9/42 isolates (21.4%)\n\nE. coli TOP10: 5 isolates (lab strain)\nE. coli DH5-Î±: 2 isolates (lab strain)\nE. coli: 2 isolates (clinical)"
  },
  {
    "objectID": "resistome_analysis_report.html#sequence-types-mlst",
    "href": "resistome_analysis_report.html#sequence-types-mlst",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.2 Sequence Types (MLST)",
    "text": "2.2 Sequence Types (MLST)\n\n\n\n\n\n\n\n\nFigureÂ 2: Distribution of sequence types among typed isolates\n\n\n\n\n\n\n\n\n\nTableÂ 2: Summary of sequence types and their clinical significance\n\n\n\n\n\n\nST\nn\nPercentage\nSpecies\nClinical.Significance\n\n\n\n\nST307\n16\n50.0\nK. pneumoniae\nGlobal high-risk clone\n\n\nST101\n7\n21.9\nK. pneumoniae\nMDR clone\n\n\nST512\n5\n15.6\nK. pneumoniae\nEmerging high-risk clone\n\n\nST131\n2\n6.3\nE. coli\nGlobal E. coli pandemic clone\n\n\nST147\n2\n6.3\nK. pneumoniae\nMDR K. pneumoniae clone"
  },
  {
    "objectID": "resistome_analysis_report.html#clinical-sources",
    "href": "resistome_analysis_report.html#clinical-sources",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.3 Clinical Sources",
    "text": "2.3 Clinical Sources\n\n\n\n\n\n\n\n\nFigureÂ 3: Distribution of clinical specimen types"
  },
  {
    "objectID": "resistome_analysis_report.html#capsular-types-kl",
    "href": "resistome_analysis_report.html#capsular-types-kl",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.4 Capsular Types (KL)",
    "text": "2.4 Capsular Types (KL)\n\n\n\n\n\n\nImportantPerfect KL-ST Association\n\n\n\nEach capsular type is exclusively associated with one sequence type, suggesting stable clonal lineages:\n\nKL107 â†”ï¸ ST512 (n=4)\nKL102 â†”ï¸ ST307 (n=2)\nKL17 â†”ï¸ ST101 (n=2)\nKL64 â†”ï¸ ST147 (n=2)\n\nOnly 23.8% (10/42) of isolates have capsular typing data, but the perfect association is striking."
  },
  {
    "objectID": "resistome_analysis_report.html#ceftazidime-avibactam-caz-avi-resistance",
    "href": "resistome_analysis_report.html#ceftazidime-avibactam-caz-avi-resistance",
    "title": "Comprehensive Resistome Analysis",
    "section": "3.1 Ceftazidime-Avibactam (CAZ-AVI) Resistance",
    "text": "3.1 Ceftazidime-Avibactam (CAZ-AVI) Resistance\n\n\n\n\n\n\n\n\nFigureÂ 4: Distribution of CAZ-AVI MIC values"
  },
  {
    "objectID": "resistome_analysis_report.html#caz-avi-resistance-by-sequence-type",
    "href": "resistome_analysis_report.html#caz-avi-resistance-by-sequence-type",
    "title": "Comprehensive Resistome Analysis",
    "section": "3.2 CAZ-AVI Resistance by Sequence Type",
    "text": "3.2 CAZ-AVI Resistance by Sequence Type\n\n\n\n\n\n\n\n\nFigureÂ 5: CAZ-AVI resistance stratified by sequence type\n\n\n\n\n\n\n\n\n\n\n\nWarningST307 Heterogeneous Resistance\n\n\n\nST307 shows a 50/50 split between intermediate and resistant isolates, suggesting:\n\nEvolving resistance mechanisms within this clone\nPotential for further resistance development\nNeed for careful monitoring"
  },
  {
    "objectID": "resistome_analysis_report.html#multi-antibiotic-resistance-heatmap",
    "href": "resistome_analysis_report.html#multi-antibiotic-resistance-heatmap",
    "title": "Comprehensive Resistome Analysis",
    "section": "3.3 Multi-Antibiotic Resistance Heatmap",
    "text": "3.3 Multi-Antibiotic Resistance Heatmap\n\n\n\n\n\n\n\n\nFigureÂ 6: Median MIC values across antibiotics by sequence type"
  },
  {
    "objectID": "resistome_analysis_report.html#blakpc-31-the-universal-carbapenemase",
    "href": "resistome_analysis_report.html#blakpc-31-the-universal-carbapenemase",
    "title": "Comprehensive Resistome Analysis",
    "section": "4.1 blaKPC-31: The Universal Carbapenemase",
    "text": "4.1 blaKPC-31: The Universal Carbapenemase\n\n\n\n\n\n\n\n\nFigureÂ 7: blaKPC-31 prevalence across species and sequence types\n\n\n\n\n\n\n\n\n\n\n\nImportantUniversal KPC-31 Carriage\n\n\n\n100% of isolates (42/42) carry blaKPC-31, including:\n\nAll K. pneumoniae isolates\nAll E. coli isolates (including lab strains)\nAll sequence types\nBoth clinical and environmental isolates\n\nThis indicates a KPC-31-specific collection or outbreak."
  },
  {
    "objectID": "resistome_analysis_report.html#resistance-gene-profiles-by-clone",
    "href": "resistome_analysis_report.html#resistance-gene-profiles-by-clone",
    "title": "Comprehensive Resistome Analysis",
    "section": "4.2 Resistance Gene Profiles by Clone",
    "text": "4.2 Resistance Gene Profiles by Clone\n\n\n\n\n\n\n\n\nFigureÂ 8: Resistance gene profiles for isolates with capsular typing\n\n\n\n\n\n\n\n\n\nTableÂ 3: Summary of resistance genes by KL/ST combination\n\n\n\n\n\n\nClone\nTotal.Genes\nBeta.lactamases\nKey.Features\n\n\n\n\nKL64 (ST147)\n15\nKPC-31, CTX-M-15, TEM-1B, SHV-11, OXA-1\nMost genes; fosfomycin resistance\n\n\nKL102 (ST307)\n13\nKPC-31, CTX-M-15, TEM-1B, SHV-28, OXA-1\nqnrB1 quinolone resistance\n\n\nKL107 (ST512)\n12\nKPC-31, TEM-1A, SHV-158\nIncX3 plasmid-associated\n\n\nKL17 (ST101)\n5\nKPC-31, SHV-1\narmA (pan-AMG resistance)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNoteNotable Findings\n\n\n\n\nKL64 (ST147): Highest gene count (15), includes fosA (fosfomycin resistance)\nKL17 (ST101): Lowest gene count (5), but includes armA conferring pan-aminoglycoside resistance\nKL102 (ST307): Carries qnrB1 providing quinolone resistance\nKL107 (ST512): Associated with IncX3 plasmid"
  },
  {
    "objectID": "resistome_analysis_report.html#kl-st-perfect-association",
    "href": "resistome_analysis_report.html#kl-st-perfect-association",
    "title": "Comprehensive Resistome Analysis",
    "section": "5.1 KL-ST Perfect Association",
    "text": "5.1 KL-ST Perfect Association\n\n\n\n\n\n\n\n\nFigureÂ 9: Perfect 1:1 association between capsular types and sequence types"
  },
  {
    "objectID": "resistome_analysis_report.html#caz-avi-resistance-by-capsular-type",
    "href": "resistome_analysis_report.html#caz-avi-resistance-by-capsular-type",
    "title": "Comprehensive Resistome Analysis",
    "section": "5.2 CAZ-AVI Resistance by Capsular Type",
    "text": "5.2 CAZ-AVI Resistance by Capsular Type\n\n\n\n\n\n\n\n\nFigureÂ 10: CAZ-AVI resistance profiles differ dramatically by capsular type\n\n\n\n\n\n\n\n\n\nTableÂ 4: CAZ-AVI resistance profiles by capsular type\n\n\n\n\n\n\nKL.Type\nST\nn\nMedian.MIC\nResistance.Status\nClinical.Concern\n\n\n\n\nKL64\nST147\n2\n256\n100% Resistant\nVery High\n\n\nKL17\nST101\n2\n130\n100% Resistant\nVery High\n\n\nKL107\nST512\n4\n48\n100% Resistant\nHigh\n\n\nKL102\nST307\n2\n12\n100% Intermediate\nModerate"
  },
  {
    "objectID": "resistome_analysis_report.html#inc-group-distribution",
    "href": "resistome_analysis_report.html#inc-group-distribution",
    "title": "Comprehensive Resistome Analysis",
    "section": "6.1 Inc Group Distribution",
    "text": "6.1 Inc Group Distribution\n\n\n\n\n\n\n\n\nFigureÂ 11: Prevalence of major incompatibility groups"
  },
  {
    "objectID": "resistome_analysis_report.html#inc-groups-by-clone",
    "href": "resistome_analysis_report.html#inc-groups-by-clone",
    "title": "Comprehensive Resistome Analysis",
    "section": "6.2 Inc Groups by Clone",
    "text": "6.2 Inc Groups by Clone\n\n\n\n\n\n\n\n\nFigureÂ 12: Incompatibility group distribution by KL/ST combination\n\n\n\n\n\n\n\n\n\n\n\nImportantClone-Specific Plasmid Profiles\n\n\n\n\nKL107 (ST512): IncX3 (100%) - fixed, likely carries blaKPC-31\nKL17 (ST101): IncR (50%) - may carry armA gene\nKL64 (ST147): IncF family (50%) - high HGT potential\nKL102 (ST307): NO Inc groups detected - chromosomal integration?"
  },
  {
    "objectID": "resistome_analysis_report.html#horizontal-gene-transfer-evidence",
    "href": "resistome_analysis_report.html#horizontal-gene-transfer-evidence",
    "title": "Comprehensive Resistome Analysis",
    "section": "6.3 Horizontal Gene Transfer Evidence",
    "text": "6.3 Horizontal Gene Transfer Evidence\n\n\n\n\n\n\n\n\nFigureÂ 13: Plasmid diversity indicates horizontal gene transfer potential\n\n\n\n\n\n\n\n\n\nTableÂ 5: Evidence for horizontal gene transfer by Inc group\n\n\n\n\n\n\nInc.Group\nDistribution\nHGT.Evidence\nSignificance\n\n\n\n\nIncFIB(K) / IncFII(K)\n4 different STs\nâ˜…â˜…â˜…â˜…â˜… High\nActive dissemination within K. pneumoniae\n\n\nIncX3\nST512 only\nâ˜…â˜†â˜†â˜†â˜† None\nClone-specific, stable, not spreading\n\n\nIncR\nPrimarily ST101\nâ˜…â˜…â˜†â˜†â˜† Limited\nMay carry armA, limited to one clone\n\n\nIncN\nRare, isolated\nâ˜…â˜…â˜…â˜†â˜† Moderate\nRecent acquisition, broad host range potential"
  },
  {
    "objectID": "resistome_analysis_report.html#relationships-between-plasmids-genes-and-resistance",
    "href": "resistome_analysis_report.html#relationships-between-plasmids-genes-and-resistance",
    "title": "Comprehensive Resistome Analysis",
    "section": "7.1 Relationships Between Plasmids, Genes, and Resistance",
    "text": "7.1 Relationships Between Plasmids, Genes, and Resistance\n\n\n\n\n\n\n\n\nFigureÂ 14: Integrated view of plasmid complexity, gene burden, and resistance levels\n\n\n\n\n\n\n\n\n\n\n\nNoteKey Paradoxes\n\n\n\n\nKL102 (ST307): Zero Inc groups but 13 resistance genes â†’ Chromosomal integration?\nKL17 (ST101): High plasmid complexity (2.3) but only 5 genes â†’ Quality over quantity (armA effect)\nKL64 (ST147): Most genes (15) and highest MIC (256) â†’ Synergistic effects"
  },
  {
    "objectID": "resistome_analysis_report.html#summary-table-clone-characteristics",
    "href": "resistome_analysis_report.html#summary-table-clone-characteristics",
    "title": "Comprehensive Resistome Analysis",
    "section": "7.2 Summary Table: Clone Characteristics",
    "text": "7.2 Summary Table: Clone Characteristics\n\n\n\n\nTableÂ 6: Comprehensive summary of clone characteristics\n\n\n\n\n\n\nClone\nn\nCAZ.AVI\nResistance.Genes\nKey.Genes\nDominant.Plasmid\nHGT.Risk\nClinical.Priority\n\n\n\n\nKL107 (ST512)\n4\nResistant (48)\n12\nblaKPC-31, blaTEM-1A\nIncX3 (100%)\nLow\nHigh\n\n\nKL17 (ST101)\n2\nResistant (130)\n5\nblaKPC-31, armA\nIncR (50%)\nLow\nVery High\n\n\nKL64 (ST147)\n2\nResistant (256)\n15\nblaKPC-31, CTX-M-15, fosA\nIncF (50%)\nHigh\nVery High\n\n\nKL102 (ST307)\n2\nIntermediate (12)\n13\nblaKPC-31, CTX-M-15, qnrB1\nNone detected\nUnknown\nMonitor"
  },
  {
    "objectID": "resistome_analysis_report.html#treatment-challenges",
    "href": "resistome_analysis_report.html#treatment-challenges",
    "title": "Comprehensive Resistome Analysis",
    "section": "8.1 Treatment Challenges",
    "text": "8.1 Treatment Challenges\n\n\n\n\n\n\nWarningExtremely Limited Treatment Options\n\n\n\nAll isolates carry blaKPC-31, resulting in:\n\nâœ— Carbapenems: Compromised by carbapenemase\nâš ï¸ CAZ-AVI: Variable resistance (35.7% high-level)\nâš ï¸ Aminoglycosides: Compromised (especially ST101 with armA)\nâš ï¸ Quinolones: Resistance common (gyrA, ParC, qnrB1)\n\n\n\n\n8.1.1 Potential Treatment Strategies\n\n\n\n\nTableÂ 7: Potential treatment options by clone type\n\n\n\n\n\n\nClone\nFirst.Line\nSecond.Line\nLast.Resort\nNotes\n\n\n\n\nKL107 (ST512)\nCefiderocol\nCarbapenem + AVI\nColistin\nIncX3-stable resistance\n\n\nKL17 (ST101)\nCefiderocol\nPlazomicin (not armA)\nColistin\narmA limits aminoglycosides\n\n\nKL64 (ST147)\nCombination therapy\nCarbapenem + fosfomycin\nColistin\nHigh gene burden, test all options\n\n\nKL102 (ST307)\nCarbapenems\nCAZ-AVI\nColistin\nBest prognosis of 4 clones"
  },
  {
    "objectID": "resistome_analysis_report.html#infection-control-priorities",
    "href": "resistome_analysis_report.html#infection-control-priorities",
    "title": "Comprehensive Resistome Analysis",
    "section": "8.2 Infection Control Priorities",
    "text": "8.2 Infection Control Priorities\n\n8.2.1 High-Risk Clones for Isolation\n\nST512 (KL107): IncX3 plasmid stable but high resistance\nST101 (KL17): armA-mediated pan-aminoglycoside resistance\nST147 (KL64): IncF plasmids with high HGT potential\n\n\n\n8.2.2 Surveillance Recommendations\n\n\n\n\n\nPriority\nTarget\nRationale\n\n\n\n\nCritical\nIncF plasmid spread\nSpreading across 4 STs, HGT evidence\n\n\nCritical\nblaKPC-31 variants\nMonitor for evolution (KPC-32, KPC-33, etc.)\n\n\nHigh\nST307 mechanism\nNo Inc groups detected - chromosomal integration?\n\n\nHigh\nCapsular typing\nStrong predictor of resistance phenotype\n\n\nModerate\nCAZ-AVI MICs\nEarly detection of resistance evolution"
  },
  {
    "objectID": "resistome_analysis_report.html#key-findings-summary",
    "href": "resistome_analysis_report.html#key-findings-summary",
    "title": "Comprehensive Resistome Analysis",
    "section": "9.1 Key Findings Summary",
    "text": "9.1 Key Findings Summary\n\nUniversal blaKPC-31 carriage (100%, 42/42) defines this collection\nST307 is dominant (50% of typed isolates) but shows heterogeneous resistance\nPerfect KL-ST associations indicate stable clonal lineages\nIncF plasmids are disseminating across multiple K. pneumoniae clones\nClone-specific resistance mechanisms:\n\nST512: IncX3-based (stable, not spreading)\nST101: IncR-based (armA-mediated pan-AMG resistance)\nST147: IncF-based (high HGT risk)\nST307: Unknown mechanism (requires investigation)"
  },
  {
    "objectID": "resistome_analysis_report.html#critical-questions-for-further-investigation",
    "href": "resistome_analysis_report.html#critical-questions-for-further-investigation",
    "title": "Comprehensive Resistome Analysis",
    "section": "9.2 Critical Questions for Further Investigation",
    "text": "9.2 Critical Questions for Further Investigation\n\n\n\n\n\n\nTipRecommended Next Steps\n\n\n\n\nWhole plasmid sequencing: Map complete genetic context of resistance genes\nST307 mechanism: Investigate chromosomal vs cryptic plasmid integration\nIncX3 plasmid characterization: Complete sequence of ST512 blaKPC-31-bearing plasmid\nTemporal analysis: If collection dates available, track resistance evolution\nEpidemiological links: Investigate patient/ward connections for transmission chains\nFunctional studies: Test plasmid transferability and fitness costs"
  },
  {
    "objectID": "resistome_analysis_report.html#public-health-implications",
    "href": "resistome_analysis_report.html#public-health-implications",
    "title": "Comprehensive Resistome Analysis",
    "section": "9.3 Public Health Implications",
    "text": "9.3 Public Health Implications\n\n\n\n\n\n\nImportantOutbreak Potential\n\n\n\nThis collection represents either:\n\nA KPC-31-specific outbreak with multiple introductions\nA surveillance collection of endemic KPC-31 strains\nClonal expansion of resistant lineages with horizontal gene transfer\n\nThe presence of high-risk global clones (ST307, ST512, ST101, ST131, ST147) combined with active plasmid dissemination (IncF family) represents a significant public health concern requiring immediate infection control measures."
  },
  {
    "objectID": "resistome_analysis_report.html#data-source",
    "href": "resistome_analysis_report.html#data-source",
    "title": "Comprehensive Resistome Analysis",
    "section": "10.1 Data Source",
    "text": "10.1 Data Source\n\nDataset: Progetto 1 (KPC-31) versione 2.xlsx\n42 bacterial isolates\n155 variables including:\n\nBacterial identification (species, MLST, capsular typing)\nAntimicrobial susceptibility testing (MIC for ~26 antibiotics)\nResistance gene detection (36 genes)\nPlasmid replicon typing (15 incompatibility groups)"
  },
  {
    "objectID": "resistome_analysis_report.html#analytical-approach",
    "href": "resistome_analysis_report.html#analytical-approach",
    "title": "Comprehensive Resistome Analysis",
    "section": "10.2 Analytical Approach",
    "text": "10.2 Analytical Approach\nAll analyses were performed using R version 4.5.1 with the following packages:\n\ntidyverse for data manipulation and visualization\nreadxl for Excel file import\nggplot2 for graphics\nknitr and kableExtra for tables\n\n\n10.2.1 Resistance Categorization\n\nCAZ-AVI Susceptible: MIC â‰¤8 mg/L\nCAZ-AVI Intermediate: MIC 9-16 mg/L\nCAZ-AVI Resistant: MIC &gt;16 mg/L\n\n\n\n10.2.2 Statistical Notes\n\nPercentages calculated on non-missing values\nMedian MIC used for heatmaps to reduce outlier effects\nLog2 transformation applied for MIC visualization"
  },
  {
    "objectID": "resistome_analysis_report.html#complete-resistance-gene-list",
    "href": "resistome_analysis_report.html#complete-resistance-gene-list",
    "title": "Comprehensive Resistome Analysis",
    "section": "11.1 Complete Resistance Gene List",
    "text": "11.1 Complete Resistance Gene List\n\n\n\n\nTableÂ 8: Complete list of resistance genes detected in the dataset\n\n\n\n\n\n\nCategory\nGene\nMechanism\n\n\n\n\nBeta-lactamases\n\n\nBeta-lactamases\nBlaKPC-31\nCarbapenemase (KPC)\n\n\nBeta-lactamases\nBlaCTXM-15\nESBL (CTX-M)\n\n\nBeta-lactamases\nblaTEM-1A\nBeta-lactamase (TEM)\n\n\nBeta-lactamases\nblaTEM-1B\nBeta-lactamase (TEM)\n\n\nBeta-lactamases\nblaSHV-1\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nblaSHV-11\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nblaSHV-28\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nBlaSHV-106\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nBlaSHV-158\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nblaOXA-1\nBeta-lactamase (OXA)\n\n\nBeta-lactamases\nbla OXA-9\nBeta-lactamase (OXA)\n\n\nAminoglycosides\n\n\nAminoglycosides\naadA\nAminoglycoside acetyltransferase\n\n\nAminoglycosides\naaaA2\nAminoglycoside resistance\n\n\nAminoglycosides\naac(6â€²)-Ib'\nAminoglycoside acetyltransferase\n\n\nAminoglycosides\naac(6Â´)-Ib-cr\nAMG + FQ resistance\n\n\nAminoglycosides\nant(2â€²')-Ia\nAminoglycoside nucleotidyltransferase\n\n\nAminoglycosides\naac(3)-IIa\nAminoglycoside acetyltransferase\n\n\nAminoglycosides\narmA\n16S rRNA methylase (pan-AMG)\n\n\nAminoglycosides\naph(3')-Ia\nAminoglycoside phosphotransferase\n\n\nQuinolones\n\n\nQuinolones\nParC\nDNA gyrase mutation\n\n\nQuinolones\ngyrA\nDNA gyrase mutation\n\n\nQuinolones\nqnrB1\nQuinolone resistance\n\n\nOther Mechanisms\n\n\nOther\nSul1\nSulfonamide resistance\n\n\nOther\nSul2\nSulfonamide resistance\n\n\nOther\nfosA\nFosfomycin resistance"
  },
  {
    "objectID": "resistome_analysis_report.html#abbreviations",
    "href": "resistome_analysis_report.html#abbreviations",
    "title": "Comprehensive Resistome Analysis",
    "section": "11.2 Abbreviations",
    "text": "11.2 Abbreviations\n\nAMG: Aminoglycoside\nCAZ-AVI: Ceftazidime-avibactam\nESBL: Extended-spectrum beta-lactamase\nHGT: Horizontal gene transfer\nInc: Incompatibility\nKL: Capsular type (K locus)\nMDR: Multi-drug resistant\nMIC: Minimum inhibitory concentration\nMLST: Multi-locus sequence typing\nST: Sequence type"
  },
  {
    "objectID": "resistome_analysis_report.html#session-information",
    "href": "resistome_analysis_report.html#session-information",
    "title": "Comprehensive Resistome Analysis",
    "section": "11.3 Session Information",
    "text": "11.3 Session Information\n\n\nCode\nsessionInfo()\n\n\nR version 4.5.1 (2025-06-13)\nPlatform: aarch64-apple-darwin20\nRunning under: macOS Tahoe 26.3\n\nMatrix products: default\nBLAS:   /Library/Frameworks/R.framework/Versions/4.5-arm64/Resources/lib/libRblas.0.dylib \nLAPACK: /Library/Frameworks/R.framework/Versions/4.5-arm64/Resources/lib/libRlapack.dylib;  LAPACK version 3.12.1\n\nlocale:\n[1] C.UTF-8/C.UTF-8/C.UTF-8/C/C.UTF-8/C.UTF-8\n\ntime zone: Europe/Rome\ntzcode source: internal\n\nattached base packages:\n[1] stats     graphics  grDevices utils     datasets  methods   base     \n\nother attached packages:\n [1] kableExtra_1.4.0 knitr_1.50       readxl_1.4.5     lubridate_1.9.4 \n [5] forcats_1.0.1    stringr_1.6.0    dplyr_1.1.4      purrr_1.2.0     \n [9] readr_2.1.6      tidyr_1.3.1      tibble_3.3.0     ggplot2_4.0.1   \n[13] tidyverse_2.0.0 \n\nloaded via a namespace (and not attached):\n [1] gtable_0.3.6       jsonlite_2.0.0     compiler_4.5.1     tidyselect_1.2.1  \n [5] xml2_1.5.1         textshaping_1.0.4  systemfonts_1.3.1  scales_1.4.0      \n [9] yaml_2.3.12        fastmap_1.2.0      R6_2.6.1           labeling_0.4.3    \n[13] generics_0.1.4     htmlwidgets_1.6.4  svglite_2.2.2      pillar_1.11.1     \n[17] RColorBrewer_1.1-3 tzdb_0.5.0         rlang_1.1.6        stringi_1.8.7     \n[21] xfun_0.55          S7_0.2.1           viridisLite_0.4.2  timechange_0.3.0  \n[25] cli_3.6.5          withr_3.0.2        magrittr_2.0.4     digest_0.6.39     \n[29] grid_4.5.1         rstudioapi_0.17.1  hms_1.1.4          lifecycle_1.0.4   \n[33] vctrs_0.6.5        evaluate_1.0.5     glue_1.8.0         cellranger_1.1.0  \n[37] farver_2.1.2       rmarkdown_2.30     tools_4.5.1        pkgconfig_2.0.3   \n[41] htmltools_0.5.9   \n\n\n\nReport generated on: December 29, 2025\nAnalysis platform: Positron 2025.12.2 with R 4.5.1"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "",
    "text": "This website presents a comprehensive genomic and phenotypic analysis of 42 bacterial isolates from the KPC-31 resistome project. The collection includes carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates with detailed molecular characterization.\n\n\n\n\n\n\nImportantCritical Finding\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, making this a KPC-31-specific collection with significant clinical and epidemiological implications."
  },
  {
    "objectID": "index.html#welcome",
    "href": "index.html#welcome",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "",
    "text": "This website presents a comprehensive genomic and phenotypic analysis of 42 bacterial isolates from the KPC-31 resistome project. The collection includes carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates with detailed molecular characterization.\n\n\n\n\n\n\nImportantCritical Finding\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, making this a KPC-31-specific collection with significant clinical and epidemiological implications."
  },
  {
    "objectID": "index.html#quick-summary",
    "href": "index.html#quick-summary",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Quick Summary",
    "text": "Quick Summary\n\n\n\nDataset Overview\n\n42 bacterial isolates\n155 variables analyzed\n26 antibiotics tested\n36 resistance genes detected\n15 plasmid Inc groups identified\n\n\n\n\nKey Findings\n\n78.6% K. pneumoniae\nST307 most prevalent (50%)\n100% blaKPC-31 positive\nHigh CAZ-AVI resistance (35.7%)\nActive plasmid dissemination"
  },
  {
    "objectID": "index.html#analysis-sections",
    "href": "index.html#analysis-sections",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Analysis Sections",
    "text": "Analysis Sections\n\nFull Report\nAccess the complete analysis including:\n\nBacterial Characterization: Species distribution, sequence types (ST), capsular types (KL)\nResistance Phenotypes: MIC distributions for 26 antibiotics, resistance patterns by clone\nResistance Genotypes: Comprehensive gene profiling, blaKPC-31 analysis\nPlasmid Analysis: Incompatibility groups, horizontal gene transfer evidence\nClinical Implications: Treatment recommendations, infection control priorities"
  },
  {
    "objectID": "index.html#highlights",
    "href": "index.html#highlights",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Highlights",
    "text": "Highlights\n\nSpecies DistributionHigh-Risk ClonesPlasmid FindingsClinical Impact\n\n\nKlebsiella pneumoniae dominates the collection (78.6%, n=33), with E. coli variants comprising 21.4%.\n\n\nFive high-risk sequence types identified: - ST307 (n=16): Global high-risk clone with heterogeneous resistance - ST512 (n=5): IncX3 plasmid-associated, 100% CAZ-AVI resistant - ST101 (n=7): armA-mediated pan-aminoglycoside resistance - ST147 (n=2): IncF plasmids with high HGT potential - ST131 (n=2): E. coli pandemic clone\n\n\n\nIncF plasmids spreading across 4 different sequence types\nIncX3 fixed in ST512 (100% prevalence)\n62% of isolates have no detectable Inc groups (chromosomal integration?)\n\n\n\nLimited treatment options due to: - Universal blaKPC-31 carriage - Variable CAZ-AVI resistance (35.7% high-level) - Multiple resistance mechanisms per isolate - Active horizontal gene transfer"
  },
  {
    "objectID": "index.html#key-visualizations",
    "href": "index.html#key-visualizations",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Key Visualizations",
    "text": "Key Visualizations\nThe full report contains interactive visualizations showing:\n\nSpecies and sequence type distributions\nCAZ-AVI resistance patterns by clone\nMulti-antibiotic resistance heatmaps\nResistance gene profiles\nPlasmid incompatibility group networks\nIntegrated analysis of plasmids, genes, and phenotypes"
  },
  {
    "objectID": "index.html#study-significance",
    "href": "index.html#study-significance",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Study Significance",
    "text": "Study Significance\nThis analysis reveals:\n\nUniversal blaKPC-31 dissemination across multiple high-risk clones\nPerfect KL-ST associations indicating stable clonal lineages\nClone-specific resistance mechanisms (plasmid-based vs chromosomal)\nActive horizontal gene transfer of IncF plasmids within K. pneumoniae\nUrgent need for infection control measures\n\n\n\n\n\n\n\nWarningPublic Health Concern\n\n\n\nThe combination of high-risk global clones (ST307, ST512, ST101, ST131, ST147) with active plasmid dissemination represents a significant public health threat requiring immediate intervention."
  },
  {
    "objectID": "index.html#navigation",
    "href": "index.html#navigation",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Navigation",
    "text": "Navigation\n\nFull Report: Complete analysis with all figures and tables\nAbout: Methods, data sources, and technical details\n\n\nLast updated: December 27, 2025"
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html",
    "href": "resistome_genotype_phenotype_final.html",
    "title": "",
    "section": "",
    "text": "CodeShow All CodeHide All CodeView Source"
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#overview",
    "href": "resistome_genotype_phenotype_final.html#overview",
    "title": "",
    "section": "Overview",
    "text": "Overview\nThis section examines the relationship between beta-lactamase gene carriage (resistome) and antimicrobial susceptibility phenotypes (MIC values) across the 42 KPC-31-producing isolates. While all isolates carry blaKPC-31, they exhibit considerable diversity in additional beta-lactamase genes, which may contribute to variations in resistance profiles."
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#beta-lactamase-gene-distribution",
    "href": "resistome_genotype_phenotype_final.html#beta-lactamase-gene-distribution",
    "title": "",
    "section": "Beta-lactamase Gene Distribution",
    "text": "Beta-lactamase Gene Distribution\n\nOverall Prevalence\nExcluding the universal blaKPC-31 gene, 13 additional beta-lactamase genes were detected across the collection:\n\n\nCode\n# Calculate gene prevalence from data\ngene_prev &lt;- colSums(analysis_data[, betalactamase_cols_names], na.rm = TRUE)\ngene_prev_sorted &lt;- sort(gene_prev, decreasing = TRUE)\n\n# Gene classification (based on literature)\ngene_classification &lt;- c(\n  \"blaSHV_28\" = \"ESBL\",\n  \"BlaCTXM_15\" = \"ESBL\", \n  \"blaOXA_1\" = \"Narrow-spectrum\",\n  \"blaTEM_1B\" = \"Narrow-spectrum\",\n  \"bla_TEM_1\" = \"Narrow-spectrum\",\n  \"blaTEM_1A\" = \"Narrow-spectrum\",\n  \"bla_OXA_9\" = \"Narrow-spectrum\",\n  \"blaSHV_1\" = \"Narrow-spectrum\",\n  \"blaSHV_11\" = \"ESBL\",\n  \"bla_OXA_18\" = \"Narrow-spectrum\",\n  \"BlaSHV_106\" = \"ESBL\",\n  \"BlaSHV_158\" = \"ESBL\",\n  \"blaKPC\" = \"Carbapenemase\"\n)\n\n# Create display names (with hyphens for readability)\ndisplay_names &lt;- gsub(\"_\", \"-\", names(gene_prev_sorted))\n\ngene_prevalence_summary &lt;- data.frame(\n  Gene = display_names,\n  n = as.integer(gene_prev_sorted),\n  Percentage = round(100 * gene_prev_sorted / nrow(analysis_data), 1)\n) |&gt;\n  filter(n &gt; 0) |&gt;\n  mutate(Classification = gene_classification[names(gene_prev_sorted)])\n\nkable(gene_prevalence_summary, \n      col.names = c(\"Gene\", \"Isolates (n)\", \"Prevalence (%)\", \"Classification\"),\n      align = c(\"l\", \"r\", \"r\", \"l\")) |&gt;\n  kable_styling(bootstrap_options = c(\"striped\", \"hover\", \"condensed\"))\n\n\n\nPrevalence of beta-lactamase genes (excluding blaKPC-31)\n\n\n\nGene\nIsolates (n)\nPrevalence (%)\nClassification\n\n\n\n\nblaSHV_28\nblaSHV-28\n14\n33.3\nESBL\n\n\nBlaCTXM_15\nBlaCTXM-15\n11\n26.2\nESBL\n\n\nblaOXA_1\nblaOXA-1\n10\n23.8\nNarrow-spectrum\n\n\nblaTEM_1B\nblaTEM-1B\n9\n21.4\nNarrow-spectrum\n\n\nbla_TEM_1\nbla-TEM-1\n6\n14.3\nNarrow-spectrum\n\n\nblaTEM_1A\nblaTEM-1A\n5\n11.9\nNarrow-spectrum\n\n\nbla_OXA_9\nbla-OXA-9\n5\n11.9\nNarrow-spectrum\n\n\nblaSHV_1\nblaSHV-1\n2\n4.8\nNarrow-spectrum\n\n\nblaSHV_11\nblaSHV-11\n2\n4.8\nESBL\n\n\nbla_OXA_18\nbla-OXA-18\n2\n4.8\nNarrow-spectrum\n\n\nBlaSHV_106\nBlaSHV-106\n1\n2.4\nESBL\n\n\nBlaSHV_158\nBlaSHV-158\n1\n2.4\nESBL\n\n\nblaKPC\nblaKPC\n1\n2.4\nCarbapenemase\n\n\n\n\n\nKey observations:\n\nThe most prevalent gene is blaSHV-28 (33.3%), an ESBL found predominantly in K. pneumoniae\nBlaCTXM-15 (26.2%) is the second most common ESBL, exclusive to K. pneumoniae in this collection\nblaOXA-1 (23.8%), a narrow-spectrum Î²-lactamase, shows interesting associations with susceptibility patterns\nOne isolate carries an additional carbapenemase gene (blaKPC, non-KPC-31 variant)\n45% of isolates (n=19) carry no additional beta-lactamase genes beyond blaKPC-31\n\n\n\nGene Burden Distribution\n\n\nCode\nburden_data &lt;- as.data.frame(table(analysis_data$n_betalactamases))\ncolnames(burden_data) &lt;- c(\"n_genes\", \"n_isolates\")\nburden_data$n_genes &lt;- as.integer(as.character(burden_data$n_genes))\n\nggplot(burden_data, aes(x = factor(n_genes), y = n_isolates)) +\n  geom_col(fill = \"#2C7FB8\", alpha = 0.8) +\n  geom_text(aes(label = n_isolates), vjust = -0.5, size = 4, fontface = \"bold\") +\n  labs(title = \"Beta-lactamase Gene Burden\",\n       subtitle = \"Number of additional beta-lactamase genes per isolate (excluding KPC-31)\",\n       x = \"Number of Additional Beta-lactamase Genes\",\n       y = \"Number of Isolates\") +\n  theme_minimal() +\n  theme(plot.title = element_text(face = \"bold\", size = 14)) +\n  ylim(0, max(burden_data$n_isolates) * 1.15)\n\n\n\n\n\nDistribution of beta-lactamase gene count per isolate\n\n\n\n\n\nModal gene burden: 0 genes (45% of isolates rely solely on blaKPC-31)\n19% of isolates carry 4 beta-lactamase genes (the second peak)\nOne isolate carries 6 additional genes, representing maximum gene burden\nBimodal distribution suggests two distinct patterns: minimal accessory resistance vs.Â extensive gene acquisition"
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#species-specific-gene-distribution",
    "href": "resistome_genotype_phenotype_final.html#species-specific-gene-distribution",
    "title": "",
    "section": "Species-Specific Gene Distribution",
    "text": "Species-Specific Gene Distribution\n\n\n\n\n\n\nNoteStudy Population Note\n\n\n\nThe collection comprises 33 K. pneumoniae clinical isolates and 9 E. coli isolates (including 7 laboratory strains: 5 TOP10 and 2 DH5-Î±). The laboratory strains were likely used for plasmid characterization studies.\n\n\n\nGene Prevalence by Species\n\n\nCode\n# Prepare data for visualization - order genes BEFORE pivoting\ngene_comparison_plot &lt;- gene_species_comparison |&gt;\n  filter(KP_n &gt; 0 | EC_n &gt; 0) |&gt;\n  mutate(\n    Total_pct = KP_pct + EC_pct,\n    Gene = factor(Gene, levels = Gene[order(Total_pct, decreasing = TRUE)]),\n    Gene_display = gsub(\"_\", \"-\", Gene)  # For display with hyphens\n  ) |&gt;\n  pivot_longer(cols = c(KP_pct, EC_pct), \n               names_to = \"Species\", \n               values_to = \"Percentage\") |&gt;\n  mutate(\n    Species = ifelse(Species == \"KP_pct\", \"K. pneumoniae (n=33)\", \"E. coli (n=9)\")\n  ) |&gt;\n  filter(Percentage &gt; 0)\n\nggplot(gene_comparison_plot, aes(x = Gene_display, y = Percentage, fill = Species)) +\n  geom_bar(stat = \"identity\", position = \"dodge\", alpha = 0.8) +\n  scale_fill_manual(values = c(\"K. pneumoniae (n=33)\" = \"#2C7FB8\", \n                                \"E. coli (n=9)\" = \"#F46D43\")) +\n  labs(title = \"Beta-lactamase Gene Prevalence by Species\",\n       subtitle = \"K. pneumoniae vs E. coli isolates\",\n       x = \"Beta-lactamase Gene\",\n       y = \"Prevalence (%)\",\n       fill = \"Species\") +\n  theme_minimal() +\n  theme(axis.text.x = element_text(angle = 45, hjust = 1, size = 9),\n        plot.title = element_text(face = \"bold\", size = 14),\n        legend.position = \"top\") +\n  coord_flip()\n\n\n\n\n\n\n\n\nFigureÂ 1: Beta-lactamase gene prevalence stratified by species\n\n\n\n\n\n\n\n\n\n\n\nImportantSpecies-Specific Gene Patterns\n\n\n\nK. pneumoniae-enriched genes:\n\nblaSHV-28 (42.4% in KP, 0% in EC) - highly K. pneumoniae-specific\nBlaCTXM-15 (33.3% in KP, 0% in EC) - completely absent from E. coli\nblaOXA-1 (30.3% in KP, 0% in EC) - K. pneumoniae-exclusive in this collection\n\nE. coli-enriched genes:\n\nbla_OXA-9 (22.2% in EC vs 9.1% in KP)\nbla_OXA-18 (22.2% in EC, 0% in KP) - E. coli-exclusive\nblaTEM-1B (22.2% in EC vs 21.2% in KP) - found in both species\n\nInterpretation: The pronounced species-specific clustering suggests that beta-lactamase gene acquisition follows species-adapted evolutionary pathways. This likely reflects differences in mobile genetic element compatibility (e.g., plasmid host range) and/or divergent selective pressures between the two species in clinical and laboratory environments."
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#genotype-phenotype-associations",
    "href": "resistome_genotype_phenotype_final.html#genotype-phenotype-associations",
    "title": "",
    "section": "Genotype-Phenotype Associations",
    "text": "Genotype-Phenotype Associations\n\nBeta-lactamase Genes and Antibiotic Susceptibility\nAnalysis of associations between individual beta-lactamase genes and MIC values for key antibiotics revealed several notable patterns:\n\n\nCode\n# Perform statistical analysis for major genes\nmajor_genes &lt;- names(gene_prev_sorted)[gene_prev_sorted &gt;= 5]\ngene_mic_comparisons &lt;- list()\n\nfor(gene in major_genes) {\n  key_antibiotics_analysis &lt;- c(\"CAZ_AVI\", \"CAZ\", \"FEP\", \"ATM\", \"C/T\", \"PIP__TAZ\", \"MER\")\n  \n  for(abx in key_antibiotics_analysis) {\n    if(abx %in% colnames(analysis_data)) {\n      with_gene &lt;- analysis_data[[abx]][analysis_data[[gene]] == 1]\n      without_gene &lt;- analysis_data[[abx]][analysis_data[[gene]] == 0]\n      \n      with_gene &lt;- with_gene[!is.na(with_gene)]\n      without_gene &lt;- without_gene[!is.na(without_gene)]\n      \n      if(length(with_gene) &gt;= 3 & length(without_gene) &gt;= 3) {\n        median_with &lt;- median(with_gene)\n        median_without &lt;- median(without_gene)\n        \n        fold_change &lt;- if(median_without &gt; 0) median_with / median_without else NA\n        \n        test_result &lt;- wilcox.test(with_gene, without_gene)\n        p_val &lt;- test_result$p.value\n        \n        # Store results if notable (p &lt; 0.1 or FC &gt; 2 or FC &lt; 0.5)\n        if(!is.na(p_val) && (p_val &lt; 0.1 || (!is.na(fold_change) && (fold_change &gt; 2 || fold_change &lt; 0.5)))) {\n          gene_mic_comparisons[[length(gene_mic_comparisons) + 1]] &lt;- list(\n            gene = gene,\n            antibiotic = abx,\n            median_with = median_with,\n            median_without = median_without,\n            fold_change = fold_change,\n            p_value = p_val,\n            n_with = length(with_gene),\n            n_without = length(without_gene)\n          )\n        }\n      }\n    }\n  }\n}\n\n\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\nWarning in wilcox.test.default(with_gene, without_gene): cannot compute exact\np-value with ties\n\n\nCode\n# Convert to dataframe\nif(length(gene_mic_comparisons) &gt; 0) {\n  associations_df &lt;- do.call(rbind, lapply(gene_mic_comparisons, function(x) {\n    data.frame(\n      Gene = gsub(\"_\", \"-\", x$gene),  # Display with hyphens\n      Antibiotic = gsub(\"_\", \"-\", x$antibiotic),\n      With_Gene = x$median_with,\n      Without_Gene = x$median_without,\n      Fold_Change = x$fold_change,\n      p_value = x$p_value,\n      n_with = x$n_with,\n      n_without = x$n_without\n    )\n  })) |&gt;\n    arrange(p_value) |&gt;\n    mutate(Direction = ifelse(Fold_Change &gt; 1, \"Higher MIC\", \"Lower MIC\"))\n  \n  # Display top associations\n  associations_display &lt;- associations_df |&gt;\n    filter(p_value &lt; 0.15) |&gt;  # Show near-significant results\n    select(Gene, Antibiotic, With_Gene, Without_Gene, Fold_Change, p_value, Direction)\n  \n  kable(associations_display,\n        col.names = c(\"Gene\", \"Antibiotic\", \"Median MIC\\n(with gene)\", \n                      \"Median MIC\\n(without)\", \"Fold Change\", \"p-value\", \"Association\"),\n        digits = c(0, 0, 1, 1, 2, 4, 0),\n        align = c(\"l\", \"l\", \"r\", \"r\", \"r\", \"r\", \"l\")) |&gt;\n    kable_styling(bootstrap_options = c(\"striped\", \"hover\", \"condensed\")) |&gt;\n    row_spec(which(associations_display$p_value &lt; 0.05), bold = TRUE) |&gt;\n    row_spec(which(associations_display$p_value &gt;= 0.05 & associations_display$p_value &lt; 0.10), \n             background = \"#FFF3CD\")\n}\n\n\n\n\nTableÂ 1: Notable genotype-phenotype associations for major beta-lactamase genes\n\n\n\n\n\n\nGene\nAntibiotic\nMedian MIC (with gene\n| Median MIC (withou\n)| Fold Chan\ne| p-val\ne|Associatio\n\n\n\n\nblaOXA-1\nCAZ-AVI\n18\n146\n0.12\n0.0662\nLower MIC\n\n\nbla-TEM-1\nCAZ-AVI\n164\n32\n5.12\n0.0909\nHigher MIC\n\n\n\n\n\n\n\n\n\n\nCode\n# Create focused visualization for two interesting genes\nplot_data &lt;- analysis_data |&gt;\n  select(ID, blaOXA_1, bla_TEM_1, CAZ_AVI, ATM, MER, PIP__TAZ) |&gt;\n  pivot_longer(cols = c(CAZ_AVI, ATM, MER, PIP__TAZ),\n               names_to = \"Antibiotic\",\n               values_to = \"MIC\") |&gt;\n  pivot_longer(cols = c(blaOXA_1, bla_TEM_1),\n               names_to = \"Gene\",\n               values_to = \"Gene_Present\") |&gt;\n  filter(!is.na(MIC)) |&gt;\n  mutate(\n    Gene_Status = ifelse(Gene_Present == 1, \"Present\", \"Absent\"),\n    log2_MIC = log2(MIC + 0.1),\n    Gene = gsub(\"_\", \"-\", Gene),  # Display with hyphens\n    Antibiotic = gsub(\"__\", \"- \", gsub(\"_\", \"-\", Antibiotic))  # Display with hyphens/spaces\n  )\n\nggplot(plot_data, aes(x = Gene_Status, y = log2_MIC, fill = Gene_Status)) +\n  geom_boxplot(outlier.shape = NA, alpha = 0.7) +\n  geom_jitter(width = 0.2, alpha = 0.6, size = 2) +\n  facet_grid(Gene ~ Antibiotic, scales = \"free_y\") +\n  scale_fill_manual(values = c(\"Absent\" = \"#E8F4F8\", \"Present\" = \"#2C7FB8\")) +\n  labs(title = \"MIC Distributions by Beta-lactamase Gene Presence\",\n       subtitle = \"blaOXA-1 and bla_TEM-1 vs. Key Antibiotics\",\n       x = \"Gene Status\",\n       y = \"log2(MIC in mg/L)\",\n       fill = \"Gene Status\") +\n  theme_minimal() +\n  theme(strip.text = element_text(face = \"bold\", size = 10),\n        plot.title = element_text(face = \"bold\", size = 14),\n        axis.text.x = element_text(angle = 45, hjust = 1),\n        legend.position = \"bottom\")\n\n\n\n\n\n\n\n\nFigureÂ 2: MIC distributions stratified by blaOXA-1 and bla_TEM-1 presence for key antibiotics\n\n\n\n\n\nKey Findings:\n\nbla_TEM-1 and CAZ-AVI resistance (p=0.091):\n\nIsolates carrying bla_TEM-1 show 5.1-fold higher CAZ-AVI MICs (median 164 vs 32 mg/L)\nSuggests possible synergistic interaction with blaKPC-31 affecting ceftazidime-avibactam susceptibility\nThis association approaches statistical significance despite small sample size (n=6 with gene)\n\nblaOXA-1 and CAZ-AVI susceptibility (p=0.066):\n\nIsolates with blaOXA-1 show 8.1-fold lower CAZ-AVI MICs (median 18 vs 146 mg/L)\nThis counterintuitive finding may reflect:\n\nClonal structure: blaOXA-1-positive isolates may belong to specific lineages with different blaKPC-31 genetic contexts (e.g., different plasmids, promoters, or expression levels)\nGene combinations: These isolates tend to carry multiple beta-lactamases (see quadruple-gene profile below)\nSampling artifact: The small E. coli subset (mostly lab strains) may influence this pattern\n\n\nblaTEM-1B and aztreonam:\n\n4-fold higher aztreonam MICs in blaTEM-1B-positive isolates\nConsistent with the hydrolytic activity of TEM variants on monobactams\n\nLimited carbapenem associations:\n\nESBL genes (BlaCTXM-15, blaSHV-28) show minimal impact on carbapenem MICs\nCarbapenem resistance is predominantly mediated by blaKPC-31\n\n\n\n\n\n\n\n\nNoteStatistical Power Considerations\n\n\n\nSeveral associations show large effect sizes (fold changes &gt;2) but limited statistical significance due to small sample sizes for rarer genes. P-values between 0.05-0.15 should be considered hypothesis-generating and warrant validation in larger, independent datasets. The paradoxical blaOXA-1 association particularly requires further investigation in a larger cohort with genomic context analysis."
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#gene-combinations-and-multi-drug-resistance",
    "href": "resistome_genotype_phenotype_final.html#gene-combinations-and-multi-drug-resistance",
    "title": "",
    "section": "Gene Combinations and Multi-Drug Resistance",
    "text": "Gene Combinations and Multi-Drug Resistance\n\nCommon Gene Profiles\n\n\nCode\n# Analyze gene profiles\nprofile_counts &lt;- sort(table(analysis_data$gene_profile), decreasing = TRUE)\n\n# Get top profiles and summarize others\ntop_profiles &lt;- head(profile_counts, 3)\nother_count &lt;- sum(tail(profile_counts, -3))\n\nprofile_summary &lt;- data.frame()\n\nfor(profile in names(top_profiles)) {\n  profile_data &lt;- analysis_data[analysis_data$gene_profile == profile, ]\n  \n  kp_count &lt;- sum(profile_data$Species_Simple == \"K. pneumoniae\")\n  ec_count &lt;- sum(profile_data$Species_Simple == \"E. coli\")\n  \n  caz_avi_median &lt;- median(profile_data$CAZ_AVI, na.rm = TRUE)\n  caz_avi_range &lt;- paste0(\"[\", \n                          round(min(profile_data$CAZ_AVI, na.rm = TRUE), 0), \n                          \"-\", \n                          round(max(profile_data$CAZ_AVI, na.rm = TRUE), 0), \n                          \"]\")\n  \n  # Display profile with hyphens\n  profile_display &lt;- ifelse(profile == \"None\", \"None (KPC-31 only)\", \n                           gsub(\"_\", \"-\", gsub(\"\\\\+\", \" + \", profile)))\n  \n  profile_summary &lt;- rbind(profile_summary, data.frame(\n    Profile = profile_display,\n    n_isolates = top_profiles[profile],\n    Percentage = round(100 * top_profiles[profile] / nrow(analysis_data), 1),\n    KP = kp_count,\n    EC = ec_count,\n    CAZ_AVI_median = caz_avi_median,\n    CAZ_AVI_range = caz_avi_range\n  ))\n}\n\n# Add \"others\" row\nif(other_count &gt; 0) {\n  profile_summary &lt;- rbind(profile_summary, data.frame(\n    Profile = sprintf(\"Other profiles (n&lt;%d each)\", min(top_profiles)),\n    n_isolates = other_count,\n    Percentage = round(100 * other_count / nrow(analysis_data), 1),\n    KP = NA,\n    EC = NA,\n    CAZ_AVI_median = NA,\n    CAZ_AVI_range = \"Variable\"\n  ))\n}\n\nkable(profile_summary,\n      col.names = c(\"Gene Profile\", \"n\", \"%\", \"KP\", \"EC\", \n                    \"CAZ-AVI\\nmedian\", \"CAZ-AVI\\nrange\"),\n      align = c(\"l\", \"r\", \"r\", \"r\", \"r\", \"r\", \"r\"),\n      digits = 1) |&gt;\n  kable_styling(bootstrap_options = c(\"striped\", \"hover\", \"condensed\")) |&gt;\n  column_spec(1, width = \"35em\")\n\n\n\n\nTableÂ 2: Most common beta-lactamase gene combinations\n\n\n\n\n\n\n\nGene Profile\nn\n%\nKP\nEC\nCAZ-AVI media\n| CAZ-AVI ran\n\n\n\n\nNone\nNone (KPC-31 only)\n19\n45.2\n12\n7\n64\n[4-256]\n\n\nBlaCTXM_15+blaTEM_1B+blaSHV_28+blaOXA_1\nBlaCTXM-15 + blaTEM-1B + blaSHV-28 + blaOXA-1\n4\n9.5\n4\n0\n12\n[12-12]\n\n\nbla_TEM_1+blaTEM_1B+bla_OXA_9+bla_OXA_18\nbla-TEM-1 + blaTEM-1B + bla-OXA-9 + bla-OXA-18\n2\n4.8\n0\n2\n164\n[164-164]\n\n\n1\nOther profiles (n&lt;2 each)\n17\n40.5\nNA\nNA\nNA\nVariable\n\n\n\n\n\n\n\n\nInsights:\n\nKPC-31-only isolates (45%):\n\nMedian CAZ-AVI MIC = 64 mg/L\nWide MIC range (4-256 mg/L) despite identical beta-lactamase gene content\nThis heterogeneity suggests variability in:\n\nblaKPC-31 expression levels\nGenetic context (plasmid copy number, promoter strength)\nPorin mutations or efflux pump expression\n\nFound in both species (12 KP, 7 EC)\n\nQuadruple-gene profile (9.5%):\n\nBlaCTXM-15 + blaTEM-1B + blaSHV-28 + blaOXA-1\nExclusive to K. pneumoniae\nAll four isolates show identical low CAZ-AVI MICs (12 mg/L)\nThis homogeneity suggests a clonal cluster with shared genetic background\nDespite carrying multiple ESBLs, shows paradoxically low CAZ-AVI resistance\n\nGene burden vs.Â resistance:\n\nNo linear relationship between gene count and MIC values\nSpecific gene identity and genomic context matter more than gene quantity\n\n\n\n\nGene Burden and Phenotype\n\n\nCode\n# Prepare data\nburden_mic_data &lt;- analysis_data |&gt;\n  filter(!is.na(CAZ_AVI)) |&gt;\n  mutate(\n    n_genes_factor = factor(n_betalactamases),\n    log2_CAZ_AVI = log2(CAZ_AVI + 0.1)\n  )\n\nggplot(burden_mic_data, aes(x = n_genes_factor, y = log2_CAZ_AVI)) +\n  geom_boxplot(fill = \"#2C7FB8\", alpha = 0.6, outlier.shape = NA) +\n  geom_jitter(width = 0.2, alpha = 0.5, size = 2.5, color = \"#2C7FB8\") +\n  stat_summary(fun = median, geom = \"text\", aes(label = sprintf(\"%.0f\", 2^..y..)), \n               vjust = -1.5, size = 3.5, fontface = \"bold\", color = \"#1C5A7D\") +\n  labs(title = \"CAZ-AVI Susceptibility by Beta-lactamase Gene Burden\",\n       subtitle = \"No linear relationship: gene context and identity are more important than count\",\n       x = \"Number of Additional Beta-lactamase Genes (excluding KPC-31)\",\n       y = \"log2(CAZ-AVI MIC in mg/L)\") +\n  theme_minimal() +\n  theme(plot.title = element_text(face = \"bold\", size = 14))\n\n\nWarning: The dot-dot notation (`..y..`) was deprecated in ggplot2 3.4.0.\nâ„¹ Please use `after_stat(y)` instead.\n\n\n\n\n\n\n\n\nFigureÂ 3: Relationship between beta-lactamase gene burden and CAZ-AVI susceptibility\n\n\n\n\n\nInterpretation:\n\nIsolates with 0-1 genes show high median MICs (64-256 mg/L)\nIsolates with 4-5 genes show lower median MICs (18-22 mg/L)\nNon-monotonic relationship indicates that gene burden alone is not predictive\nThe clonal quadruple-gene K. pneumoniae cluster drives the low MICs in the 4-gene group"
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#species-specific-phenotypic-profiles",
    "href": "resistome_genotype_phenotype_final.html#species-specific-phenotypic-profiles",
    "title": "",
    "section": "Species-Specific Phenotypic Profiles",
    "text": "Species-Specific Phenotypic Profiles\n\nAntimicrobial Susceptibility Comparison\n\n\nCode\n# Perform species comparison\nkey_antibiotics_species &lt;- c(\"CAZ_AVI\", \"CAZ\", \"FEP\", \"ATM\", \"C/T\", \"PIP__TAZ\", \"MER\", \"IMI\")\n\nspecies_comparison &lt;- data.frame()\n\nfor(abx in key_antibiotics_species) {\n  if(abx %in% colnames(analysis_data)) {\n    kp_mics &lt;- analysis_data[[abx]][analysis_data$Species_Simple == \"K. pneumoniae\"]\n    kp_mics &lt;- kp_mics[!is.na(kp_mics)]\n    \n    ec_mics &lt;- analysis_data[[abx]][analysis_data$Species_Simple == \"E. coli\"]\n    ec_mics &lt;- ec_mics[!is.na(ec_mics)]\n    \n    if(length(kp_mics) &gt;= 3 & length(ec_mics) &gt;= 3) {\n      test_result &lt;- wilcox.test(kp_mics, ec_mics)\n      \n      # Display name with hyphens\n      abx_display &lt;- gsub(\"__\", \"- \", gsub(\"_\", \"-\", abx))\n      \n      species_comparison &lt;- rbind(species_comparison, data.frame(\n        Antibiotic = abx_display,\n        KP_median = median(kp_mics),\n        KP_range = paste0(\"[\", round(min(kp_mics), 1), \"-\", round(max(kp_mics), 1), \"]\"),\n        EC_median = median(ec_mics),\n        EC_range = paste0(\"[\", round(min(ec_mics), 1), \"-\", round(max(ec_mics), 1), \"]\"),\n        p_value = test_result$p.value\n      ))\n    }\n  }\n}\n\n\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\nWarning in wilcox.test.default(kp_mics, ec_mics): cannot compute exact p-value\nwith ties\n\n\nCode\nkable(species_comparison,\n      col.names = c(\"Antibiotic\", \"KP Median\", \"KP Range\", \n                    \"EC Median\", \"EC Range\", \"p-value\"),\n      align = c(\"l\", \"r\", \"l\", \"r\", \"l\", \"r\"),\n      digits = 4) |&gt;\n  kable_styling(bootstrap_options = c(\"striped\", \"hover\", \"condensed\")) |&gt;\n  column_spec(6, background = ifelse(!is.na(species_comparison$p_value) & species_comparison$p_value &lt; 0.1, \"#FFF3CD\", \"white\"))\n\n\n\n\nTableÂ 3: Comparison of median MIC values between K. pneumoniae and E. coli\n\n\n\n\n\n\nAntibiotic\nKP Median\nKP Range\nEC Median\nEC Range\np-value\n\n\n\n\nCAZ-AVI\n48\n[12-644]\n128.00\n[4-164]\n0.3685\n\n\nCAZ\n32\n[32-256]\n32.00\n[16-256]\n1.0000\n\n\nFEP\n16\n[16-16]\n1.00\n[0.5-16]\n0.0707\n\n\nATM\n32\n[4-32]\n8.50\n[1-16]\n0.0567\n\n\nC/T\n84\n[84-84]\n84.00\n[84-84]\nNaN\n\n\nPIP--TAZ\n324\n[16-1284]\n44.00\n[8-164]\n0.0623\n\n\nMER\n2\n[0.1-16]\n0.25\n[0.1-12]\n0.8624\n\n\nIMI\n1\n[0.2-1.5]\n1.00\n[0-1]\n0.4283\n\n\n\n\n\n\n\n\n\n\nCode\n# Prepare data for species comparison plot\nspecies_plot_data &lt;- analysis_data |&gt;\n  filter(Species_Simple %in% c(\"K. pneumoniae\", \"E. coli\")) |&gt;\n  select(ID, Species_Simple, all_of(key_antibiotics_species)) |&gt;\n  pivot_longer(cols = all_of(key_antibiotics_species),\n               names_to = \"Antibiotic\",\n               values_to = \"MIC\") |&gt;\n  filter(!is.na(MIC)) |&gt;\n  mutate(\n    log2_MIC = log2(MIC + 0.1),\n    Antibiotic = gsub(\"__\", \"- \", gsub(\"_\", \"-\", Antibiotic))  # Display with hyphens\n  )\n\nggplot(species_plot_data, aes(x = Species_Simple, y = log2_MIC, fill = Species_Simple)) +\n  geom_boxplot(outlier.shape = NA, alpha = 0.7) +\n  geom_jitter(width = 0.2, alpha = 0.5, size = 2) +\n  facet_wrap(~ Antibiotic, scales = \"free_y\", ncol = 4) +\n  scale_fill_manual(values = c(\"K. pneumoniae\" = \"#2C7FB8\", \"E. coli\" = \"#F46D43\")) +\n  labs(title = \"Antibiotic Susceptibility Profiles by Species\",\n       subtitle = \"MIC distributions for key beta-lactam antibiotics\",\n       x = \"Species\",\n       y = \"log2(MIC in mg/L)\",\n       fill = \"Species\") +\n  theme_minimal() +\n  theme(axis.text.x = element_blank(),\n        axis.ticks.x = element_blank(),\n        strip.text = element_text(face = \"bold\", size = 10),\n        plot.title = element_text(face = \"bold\", size = 14),\n        legend.position = \"bottom\")\n\n\n\n\n\n\n\n\nFigureÂ 4: Species-specific antibiotic susceptibility profiles\n\n\n\n\n\nObservations:\n\nNo statistically significant differences at p&lt;0.05 threshold\nTrends approaching significance:\n\nCefepime: K. pneumoniae higher (p=0.071)\nAztreonam: K. pneumoniae higher (p=0.057)\nPiperacillin-tazobactam: K. pneumoniae higher (p=0.062)\n\nCAZ-AVI susceptibility:\n\nK. pneumoniae median = 48 mg/L\nE. coli median = 128 mg/L\nLarge within-species variability prevents statistical significance\nNote: E. coli population includes laboratory strains which may differ from clinical isolates\n\n\n\n\n\n\n\n\nTipClinical Implications\n\n\n\nDespite similar blaKPC-31 carriage, K. pneumoniae isolates trend toward higher MICs for several beta-lactams (aztreonam, piperacillin-tazobactam), likely due to higher ESBL prevalence (BlaCTXM-15, blaSHV-28). However, individual isolate susceptibility testing remains essential due to substantial within-species heterogeneity and the non-predictive nature of gene count alone."
  },
  {
    "objectID": "resistome_genotype_phenotype_final.html#summary-and-conclusions",
    "href": "resistome_genotype_phenotype_final.html#summary-and-conclusions",
    "title": "",
    "section": "Summary and Conclusions",
    "text": "Summary and Conclusions\n\nKey Genotype-Phenotype Relationships\n\nUniversal KPC-31, variable accessory resistome:\n\nAll 42 isolates carry blaKPC-31\n55% carry 1-6 additional beta-lactamase genes\nAccessory genes show strong species-specificity\n\nSpecies-specific gene acquisition patterns:\n\nK. pneumoniae preferentially acquires ESBLs (BlaCTXM-15, blaSHV-28, blaOXA-1)\nE. coli shows enrichment for OXA-9/18 variants\nReflects species-adapted evolutionary pathways and plasmid compatibility\n\nComplex genotype-phenotype relationships:\n\nbla_TEM-1 associated with higher CAZ-AVI MICs (5.1-fold, p=0.091)\nblaOXA-1 paradoxically associated with lower CAZ-AVI MICs (likely clonal effect)\nGene burden does not predict resistance level\nGenomic context and clonal background are critical determinants\n\nClonal vs.Â polyclonal patterns:\n\nQuadruple-gene K. pneumoniae cluster (n=4) shows homogeneous low CAZ-AVI MICs\nKPC-31-only isolates (n=19) show 64-fold MIC variation\nSuggests expression-level differences and genetic context effects\n\n\n\n\nClinical and Research Implications\n\n\n\n\n\n\nImportantKey Messages for Clinical Practice\n\n\n\n\nGenotypic data has limited phenotypic predictive value: The 64-fold CAZ-AVI MIC range (4-644 mg/L) among genetically similar isolates underscores the necessity of direct antimicrobial susceptibility testing for patient management.\nCAZ-AVI variability despite universal KPC-31: Clinicians should not assume uniform CAZ-AVI resistance in KPC-31 isolates. Individual testing is required, as 35.7% show high-level resistance (&gt;16 mg/L) while others remain relatively susceptible.\nSpecies trends vs.Â individual variation: While K. pneumoniae shows trends toward higher beta-lactam MICs due to ESBL co-carriage, within-species variation is substantial enough to preclude species-based treatment decisions.\nLimited value of accessory beta-lactamase testing: Knowing additional beta-lactamase gene content provides minimal added predictive value beyond phenotypic testing.\n\n\n\n\n\nFuture Directions\n\nExpression-level analysis:\n\nQuantitative RT-PCR or RNA-seq to measure blaKPC-31 and accessory gene expression\nProteomics to assess functional enzyme levels\n\nGenomic context characterization:\n\nComplete plasmid sequencing to identify genetic environments\nPromoter region analysis (blaKPC-31 upstream sequences)\nIS element and transposon mapping\n\nClonal analysis:\n\nWhole-genome sequencing for SNP-based phylogeny\nInvestigation of the quadruple-gene K. pneumoniae cluster\nAssessment of porin mutations and efflux pump variants\n\nExpanded validation:\n\nTest observed associations in larger, geographically diverse cohorts\nInclude more clinical E. coli isolates (reduce lab strain bias)\nLongitudinal studies to assess temporal stability\n\nMechanistic studies:\n\nSite-directed mutagenesis of blaKPC-31 variants\nFitness cost measurements for multi-gene carriage\nIn vitro evolution experiments under antibiotic pressure\n\n\n\nAnalysis completed: December 29, 2025\nIsolates analyzed: 42 (33 K. pneumoniae, 9 E. coli)\nBeta-lactamase genes examined: 13 (excluding universal blaKPC-31)\nAntibiotics tested: 28\nStatistical methods: Wilcoxon rank-sum tests (non-parametric)"
  }
]